Chen, Peiwen
Dey, Prasenjit http://orcid.org/0000-0001-6678-503X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (5R00CA218891-04, 1R01CA262822-01, R00CA240896)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
Article History
Received: 19 April 2022
Revised: 29 June 2022
Accepted: 30 June 2022
First Online: 11 July 2022
Competing interests
: PD has a patent pending on targeting IL-33 in cancer (U.S. Provisional Patent Application, Serial No. 63/238,531). PC has nothing to disclose.